chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pseudo- dementia type symptoms; psychosis; This is a spontaneous report from a contactable consumer (patient). A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 19Jun2021 at 11:00 (at the age of 55-years-old) as dose 2, single for COVID-19 immunisation. Medical history included depression, high blood pressure, severe west Nile virus, and encephalitis (7 years earlier) all from an unknown date. The patient previously took LAMICTAL and experienced allergy. Prior to vaccination, the patient has not been diagnosed with COVID-19. Concomitant medications included celecoxib (CELEXA), lisinopril and gabapentin (NEURONTIN) all taken for an unspecified indication, start and stop date were not reported. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 22May2021 at 12:00 (at the age of 55-years-old) for COVID-19 immunisation. On 22Jun2021 at 08:00, the patient experienced pseudo- dementia type symptoms and psychosis. The events resulted in Doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, and disability or permanent damage. Therapeutic measures were taken as a result of the events which included multiple tests, antiseizure meds, and antipsychotics. Since the vaccination the patient has not been tested for COVID-19. The patient has not recovered from the events.  The lot number for BNT162B2 was not provided and will be requested during follow up.
Starting on the third day after the shot I wake every morning with extreme dizziness which  is very severe. This also happens if I lie down for any period and then get up again. The dizziness passes in a few minutes and does not happen during the day unless I lie down again.
I am not sure what flu shot I got - whatever the standard normal shot was.    Woke up in the morning with chills and just feeling off. Diarrhea set in about Noon causing me to poop in my pants as it came on very suddenly.    I continued to diarrhea pretty consistently at least once or twice an hour for the rest of the day.   But at 3pm I started to vomit pretty violently.  I have never vomited that violently ever before.   I get a flu shot most every year, I have never had a reaction like this.   Unable to keep any food or water down; in very rough shape.
Started with injection site arm itching, proceeded within an hour to itching and hives over entire body,  with in 30 minutes of that I was short of breath, coughing and having trouble breathing
received the 1st shot of Shingrix in March 2020 / didn´t get the 2nd shot d/t Covid situation; This case was reported by a pharmacist and described the occurrence of social problem in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose in March 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were reported as follows: The age at vaccination was not reported. The reporter stated the patient received didn't get the 2nd shot due to Covid situation. The patient asked whether he should get the 2nd shot now or does he have to start the series over again with the 1st shot. Reporter had requested for more information and also confirmed if the patient had COVID-19. Reporter did not consented to follow up.
Patient presented to ED with Right sided facial droop and difficulty opening eye lids. Stating "right side of face not working." She was diagnosed in ED with Bell's Palsy.
Complaints of on the day after the vaccine her arm got very sore, red and feverish. Saturday it was worse, hot to touch and red. We reported three other patients with the same lot number with similar reactions.
Pt tested positive for COVID-19 on 09/19/2022. Deceased on 09/10/2022
INJECTION SITE REACTION. SWOLLEN, ENLARGED, REG AND WARM AROUND ENITRE DELTOID. PT SAID CAME ON A COUPLE DAYS AFTER INJECTION, AND EVENTUALLY WENT DOWN AFTER ABOUT 5 DAYS OF TYLENOL AND REPEATED ICINGS.
Redness at injection site, pain at injection site, achy and tender to touch/hot to touch at injection site, itching/no fever or chills
The pt experienced aching in the left arm, migrating from the wrist to forearm to the elbow and shoulder five days post vax. Seen by a physician on 1/23/01. The pt was prescribed Neurotin.
This spontaneous report was received from a pharmacist refers to a 52 year old female patient. The patient was allergic to NSAIDS, allergic to aspirin related medications, allergy to percocet and iodine. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX23, (lot number, expiry date and route was unknown). On an unknown date, the patient developed rash and swelling after PNEUMOVAS23. The outcome of the events were unknown. The patient sought medical attention. Additional information has been requested.
This spontaneous report was received from a nurse refers to an adult female patient of unknown age. The patient's current condition included asthma. There were no medical history, drug reactions/allergies and concomitant medications reported. On unknown dates prior to 2015, the patient was vaccinated with GARDASIL and M-M-R II (dosing details not provided). Approximately in May 2015, the patient was diagnosed with immature ovarian teratoma. Nurse reported that the patient was seen and treated by unspecified healthcare providers, and had several unspecified lab/diagnostic testing at unspecified locations on unspecified dates. The patient required medical attention and was treated with six rounds of chemotherapy with several medications including cisplatin, etoposide and bleomycin. However, the patient was not hospitalized. Nurse stated that the patient was incapacitated for an unspecified reason for an unspecified amount of time after an unspecified treatment for immature ovarian teratoma. Outcome of the event was reported as not recovered. Nurse reported that it was decided to re-vaccinate the patient with M-M-R II on unspecified date in September or October 2016, due to possible effect of chemotherapy treatment on the immunity of measles, mumps and rubella. It was unknown whether the patient was re-vaccinated or not. Reporting nurse had not assessed the causality of the event with respect to both vaccines, GARDASIL and M-M-R II. Nurse considered the event to serious due to disability. Upon internal review, the event immature ovarian teratoma was considered to be medically significant. Additional information has been requested.
redness and warmth at the injection site; redness and warmth at the injection site; her arm felt sore at the injection site; This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number 7L27G, expiry date 27th February 2022) for prophylaxis.  On 16th March 2020, the patient received Shingrix (intramuscular). On 16th March 2020, less than a day after receiving Shingrix, the patient experienced injection site pain. On 17th March 2020, the patient experienced injection site erythema and injection site warmth. On an unknown date, the outcome of the injection site erythema, injection site warmth and injection site pain were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site warmth and injection site pain to be related to Shingrix.  Additional case details were reported as follows: The patient received a dose of Shingrix in right deltoid. In evening, the patient's arm felt sore at the injection site.  One day after receiving Shingrix, the patient had redness and warmth at the injection site.  The redness was 3x5 inches.   Follow up information received other health professional on 23rd April 2020: The patient demographics details were updated. Previously administered products included LISINOPRIL COMP received on 24th December 2019.  Concurrent drug included naproxen and tizanidine received on 23th March 2020. The outcome of the injection site erythema, injection site warmth and injection site pain were recovered. The reporter considered the injection site erythema, injection site warmth and injection site pain to be related to Shingrix. The VAERS details were updated.
Information has been received from a registered nurse concerning multiple unspecified patients of unknown age and gender. The patents' concurrent conditions, medical histories and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses improperly stored PROQUAD (lot # M002055 with expiration date 11-JUL-2017, lot # M006104 with expiration date 01-AUG-2017; dose, dose number and route were unknown), for prophylaxis. The vaccines were exposed under temperature of 40.3 degrees Fahrenheit for 9 hours and 52 minutes. There were no previous temperature excursions. Data Logger was involved. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Follow up information has been received on 28-DEC-2016, the nurse stated that he would fax the patient identifiers and dates of vaccination. Additional information has been requested.; Sender's Comments: US-009507513-1611USA001695:,MERCK 1610USA011829:Mfr number.
MOTHER REPORTS THAT AFTER IMMUNIZATIONS GIVEN ON LAST VISIT, THE INFANT EXPERIENCED "TEMP TO 103ax, AND UNCONTROLLABLE CRYING X>2 DAYS." SHE DID NOT CALL US, JUST ASSUMED IT WAS THE DTaP.
A patient was administered 1st dose from vial that has been punctured and refrigerated for 23 hours; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient was administered 1st dose from vial that has been punctured and refrigerated for 23 hours) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUTICASONE PROPIONATE, CETIRIZINE HYDROCHLORIDE (CETRIZINE), CLONAZEPAM, CLOTRIMAZOLE, ESTRADIOL, NORETHISTERONE ACETATE (COMBIPATCH), DULOXETINE, HYDROXYZINE, IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (IPRATROPIUM/ALBUTEROL), LAMOTRIGINE, LISINOPRIL, METOPROLOL, OMEPRAZOLE, FLUTICASONE PROPIONATE (PROAIR [FLUTICASONE PROPIONATE]), BREXPIPRAZOLE (REXULTI) and TRIAMCINOLONE for an unknown indication.    On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient was administered 1st dose from vial that has been punctured and refrigerated for 23 hours). On 16-Jun-2021, EXPIRED PRODUCT ADMINISTERED (A patient was administered 1st dose from vial that has been punctured and refrigerated for 23 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The reporter was a Nurse practitioner who called to report an adverse event that happened at their facility, where a patient was given 1st dose of Moderna COVID-19 from a vial that has been punctured and was refrigerated for 23 hours. The reporter said that a 10-doses multi-dose vial was punctured on 15-Jun-2021 morning at 10:30AM and stayed in refrigerator through last night and was administered to a patient as a 1st dose of vaccination series today, on 16-Jun-2021 at 9AM.  No treatment information was provided.
RASH ON TRUNK OF BODY, SEVERE HEADACHE, LACK OF APPETITE, TASTE PERVERSION, SEVERE FATIGUE ("SLEPT FOR A DAY AND A HALF")
Systemic: Tinnitus-Medium, Additional Details: continuous Tinnitus since 8/16/2022 (day after receiving imm)
Vaccinated Thurs afternoon, red area on left arm continued to grow red, hot and swollen. Had fever/chills starting Friday, headache. Vomited on Sunday. Seen in ER on Sunday, began IBU and antibiotic, for cellulitis and costochondritis.
Starting July 2001 - enlarged lymph nodes in neck, achy legs, pain in right buttock, spine, and hip joints.  After 8 months of blood tests, CT scans, MRIs, doctors found Hodgkin's disease present.
fever; This is a spontaneous report from a contactable other health professional received via Medical Information Team.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at 09:00 at single dose for COVID-19 immunization.  The patient medical history and concomitant medications were not reported.  The patient experienced fever on 23Dec2020. The patient outcome of the event was unknown.    Information about Lot/Batch number has been requested.
2.5 hours post jab= rash on under upper arm of jab arm; increase of heart rate (resting) barely sore throat @ 10.5 hours post jab; heart rate almost slowed to normal resting rate
7 cm by 6 cm erythematous blanching raised rash surrounding injection site on right upper extremity.
Developed rash on back and chest/stomach approx 19 hours after injection .  Itchy all over  Eye itchiness developed 4 hrs after injection  Other symptoms were Muscle and body aches Slight cough Sore throat Face puffy Fatigue  Chest heaviness (o2 levels stayed 100 percent )
About 8 hours after receiving my shot (11 pm 4/8/2021) I started experiencing chills and low fever. 12 hours after the shot (3 am 4/9/2021), I had a temperature of 102 degrees F, took 1 Tylenol and experienced difficulty sleeping. 16 hours after the shot (7 am) I awoke with a headache followed by mild nausea (8 am). Over the course of the day, the fever and all other symptoms gradually subsided. By the morning of the next day (4/10/2021) I was completely back to normal and feeling healthy again.
Client became dizzy and nauseous immediately after receiving 3rd immunization; passed out and was unconscious for about 1 minute shortly after. Was assisted to lying position, dizziness and nausea persisted for about 15 minutes, resolved and client able to walk out on own after 30 minutes of resting, accompanied by boyfriend.
Patient complained of pain at injection site, weakness & joint stiffness.  Temperature obtained 101.6.
Rash on arm, and swollen gland; patient was advised to use cool compresses and Benadryl.
Adult vial of Pfizer was mixed for pediatric use  child was given the correct dose when error caught   no adverse reactions noted
Pain in arm last 2 weeks.  Hives started popping up on 12/23 and are continuing as of today.  Started prednisone yesterday.  New hives still appearing.  Had this same reaction to first pfizer shot in January but that reaction was 30 minutes after shot.  Prednisone started within a few days.  These hives much worse-
At around 3:30 am patient or my mum sorry having chills shivering muscle aches her temperature was 102.5 took Tylenol and fell asleep around noon that day very confused swore she took Tylenol but didn?t bell and couldn?t get off the floor again very confused lethargic MS was called temperature noted to be 106 Greece Fahrenheit was taken to the hospital given three bags of fluids was given Tylenol even though patient was argumentative and said she took Tylenol continue to be confused and lethargic throughout the stay at the hospital upon leaving hospital at 8 pm temperature was 100.7 patient was able to walk
About a week after my shot I started experiencing a tingling in the middle of my back, it comes and goes, worse when I sit down, I went to ER after it didn't get any better a week later; This is a spontaneous report from a contactable consumer (patient himself). A 45-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 10Apr2021 12:45 (age at vaccination: 45 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included none. Concomitant medication(s) included lysine, multivitamin and allergy and acid reducer. The patient had no known allergies. The patient received vaccine in a pharmacy. The patient had no other vaccine in four weeks. On 16Apr2021 12:00, the patient about a week after his shot started experiencing a tingling in the middle of my back, it comes and goes, worse when he sits down. He went to emergency room after it didn't get any better a week later. The patient received Muscle relaxers and ibuprofen as treatment for the adverse event. The patient was worried and was not going to take second shot. On an unknown date, the patient underwent computerised tomogram and x-ray treatment with unknown results. It was unknown if patient had covid before vaccination nor was tested since vaccination. The outcome of the event was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 14-MAR-2023, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This is one of several cases received from the same reporter. ; Sender's Comments:  US-009507513-2304USA002221:
My symptoms were a fever of 102-103, coughing, fatigue, and bronchial symptoms. I took a home COVID-19 and it came positive. I went to the doctor, and they prescribed me PAXLOVID which helped a lot. They did a blood test, and my blood oxygen was at 95. I still have a little lingering cough.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild, Additional Details: Patient fainted briefly after getting Pfizer vaccine.  She bumped her head on the wall when she passed out.  She was alert and awake by the time I came out of the pharmacy.  Mom was there to make sure she did not fall on the ground and also mentioned she has anxiety with vaccinations.  I monitored her for 30 minutes after the incident.  I gave her water, a granola bar, and an ice pack to help with sysmptoms.  She was alert and okay when the family left the pharmacy.
After receiving the shot on my upper left arm near the shoulder, I had a severe allergic reaction. After 2 hours, a painful rash formed around the injection site and the other parts of the upper arm. I still have markings left from the rash. After 4 hours I was feeling nauseous and dizzy to the point I decided to just lay down and rest. I woke up from the nap as the symptoms worsen and threw up multiple times. About 11 hours after the injection, I was having trouble with breathing and it gradually worsened. I tried breathing by doing heavy breathing for two hours. As I felt like dying from suffocation, my partner decided to call 911 and also called the emergency room nearby to speak to the nurse.  We are informed that this is a serious reaction and I needed to be treated ASAP. I took an antihistamine as recommended by a paramedic and the emergency room nurse. I was able to breathe normally after 30 minutes. The day after, I couldn't breathe in deep since my lung felt as it was bruised from heavy breathing. As of now, I still have some marks from the rash, and muscle tension/sore on my left armpit.
no known side effects; an improperly stored (supported) dose of PROQUAD was administered today; This spontaneous report was received from a medical assistant and refers to a 1-year-old male patient. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 27-JUL-2021, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) lot # T037956, expiration date 09-MAY-2022 (dose number, dose and route of administration were not reported) for prophylaxis.  The vaccine was stored improperly for the time frame of 1 hour and 15 minutes in the temperature of -12.4 degrees Celsius (C) and for 1 hour and 30 minutes in the temperature of -3.2 C. The previous temperature excursion was reported as time frame of 1 hour and 40 minutes in the temperature -8.6 C. Digital Data Logger was involved.  There were no known side effects.
Time of onset I felt very nauseated  2 hrs later felt HR elevated and checked, 108 and fluctuated between 103-126 Flush BP elevated to 176/93...normal range 120?s-135/70?s-85 Gastrointestinal issues Lasted approximately 5 hours with exception of gastrointestinal issues lasting about 24 hrs.
Large swelling from the elbow to the shoulder, redness, heat and a gray spot where the shot was adminstered. The reaction is still present 3 days post injection.
Patient hospitalized for stenosis of left carotid artery, L CEA with dacron patch within 6 weeks of receiving covid vaccination.
A non-serious spontaneous report of headache has been received from a nurse practitioner concerning a 15-year-old male, subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. On 22-Sep-2009, the patient received FLUMIST. Immediately after receiving FLUMIST the patient experienced a headache. He was treated with ibuprofen and acetaminophen. The headache was ongoing at the time of the report.